Myeloma News and Research

RSS

Racial disparities in survival rates among patients with multiple myeloma and diabetes

Patients with multiple myeloma, a blood cancer of plasma cells in the bone marrow, who also have diabetes have a reduced overall survival when compared to those without diabetes.

29 Sep 2023

Creating CAR-T cells with enhanced immune memory to fight cancer

Among available immunotherapies, the use of «CAR-T» cells is proving extremely effective against certain blood cancers, but only in half of patients.

20 Sep 2023

Annual NCCN Congress to focus on latest advances in blood cancer treatment

The National Comprehensive Cancer Network 2023 Annual Congress: Hematologic Malignancies returns to San Francisco this week, for the first time since 2019.

19 Sep 2023

Study reveals potential targets to improve the treatment of myeloma

A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has revealed crucial insights into the role of the histone methyltransferase NSD2 and its epigenetic target PKCα in causing t(4;14) translocated multiple myeloma (MM), a high-risk subtype of blood cancer, to be more aggressive and resistant to treatment.

12 Sep 2023

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma.

9 Sep 2023

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

The National Comprehensive Cancer Network today announced the publication of a new supportive care patient guideline focused on preventing and treating cancer-associated blood clots, also known as venous thromboembolism (VTE).

8 Sep 2023

Immune system plays key role in determining the duration of patients' remission from multiple myeloma

A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other top-tier cancer centers highlights the vital role that the immune system plays in determining the duration of patients' remission from multiple myeloma.

7 Sep 2023

Universal approach could potentially expand CAR T cell therapy to all blood cancers

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer.

31 Aug 2023

New oral agent shows promise in treatment of relapsed multiple myeloma

A new agent that subverts myeloma cells from within while also subjecting them to an immune system attack produced impressive responses in combination with dexamethasone in patients with multiple myeloma that had relapsed and stopped responding to all currently available therapies, a clinical trial conducted by researchers at Dana-Farber Cancer Institute and around the world has found.

30 Aug 2023

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Short-lived proteins control gene expression in cells to carry out a number of vital tasks, from helping the brain form connections to helping the body mount an immune defense.

24 Aug 2023

Associations between cardiorespiratory fitness in young men and the incidence of site-specific cancer

A recent study assessed the association between cardiorespiratory fitness and some cancers in healthy young men.

21 Aug 2023

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Researchers examined the association between moderate alcohol intake and specific cancer risks.

21 Aug 2023

A peek at Big Pharma’s playbook that leaves many Americans unable to afford their drugs

America's pharmaceutical giants are suing this summer to block the federal government's first effort at drug price regulation.

18 Aug 2023

How conversion between different types of cell death contributes to disease

Researchers elucidate the role of cell death in the pathogenesis of different diseases.

10 Aug 2023

NYU Langone Health included on the 2023-24 Honor Roll of top 20 hospitals

NYU Langone Health once again stands out in U.S. News & World Report's annual "Best Hospital" rankings for its unwavering commitment to exceptionalism, with its inclusion on the 2023-24 Honor Roll of the top 20 hospitals.

1 Aug 2023

UCSF Medical Center named to Honor Roll of nation's top hospitals

U.S. News & World Report ranks UCSF Health adult care among nation's top 10 hospitals in 7 specialties, Best in the West for neurology/neurosurgery and rheumatology.

1 Aug 2023

MGH opens first-of-its-kind center to eliminate lifelong immunosuppression after organ transplant

Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, officially opened the Legorreta Center for Clinical Transplant Tolerance, the first-of-its kind center in the world dedicated to preventing organ rejection after transplant surgery without the use of lifelong immunosuppressive medications.

1 Aug 2023

Myeloma News and Research

Racial disparities in survival rates among patients with multiple myeloma and diabetes

Creating CAR-T cells with enhanced immune memory to fight cancer

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Study reveals potential targets to improve the treatment of myeloma

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

Immune system plays key role in determining the duration of patients' remission from multiple myeloma

Universal approach could potentially expand CAR T cell therapy to all blood cancers

New oral agent shows promise in treatment of relapsed multiple myeloma

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Associations between cardiorespiratory fitness in young men and the incidence of site-specific cancer

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

A peek at Big Pharma’s playbook that leaves many Americans unable to afford their drugs

How conversion between different types of cell death contributes to disease

NYU Langone Health included on the 2023-24 Honor Roll of top 20 hospitals

UCSF Medical Center named to Honor Roll of nation's top hospitals

MGH opens first-of-its-kind center to eliminate lifelong immunosuppression after organ transplant

Using 'click chemistry' to create novel multi-protein anti-cancer agents

Can a low-bacterial diet improve outcomes for neutropenic cancer patients?

WHO to declare artificial sweetener aspartame as possible carcinogen

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News